Maria Rutledge - Beneficient Warrant Chief Officer
| BENFW Stock | 0.01 0.0001 1.10% |
Executive
Maria Rutledge is Chief Officer of Beneficient Warrant
| Age | 49 |
| Address | 325 North Saint Paul Street, Dallas, TX, United States, 75201 |
| Phone | 214 445 4700 |
| Web | https://www.trustben.com |
Maria Rutledge Latest Insider Activity
Tracking and analyzing the buying and selling activities of Maria Rutledge against Beneficient Warrant stock is an integral part of due diligence when investing in Beneficient Warrant. Maria Rutledge insider activity provides valuable insight into whether Beneficient Warrant is net buyers or sellers over its current business cycle. Note, Beneficient Warrant insiders must abide by specific rules, including filing SEC forms every time they buy or sell Beneficient Warrant'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Maria Rutledge over two months ago Disposition of 424 shares by Maria Rutledge of Beneficient at 5.38 subject to Rule 16b-3 | ||
Maria Rutledge over three months ago Acquisition by Maria Rutledge of 900 shares of Beneficient at 1.11 subject to Rule 16b-3 | ||
Maria Rutledge over six months ago Disposition of 424 shares by Maria Rutledge of Beneficient at 5.38 subject to Rule 16b-3 |
Beneficient Warrant Management Efficiency
The company has return on total asset (ROA) of (0.0978) % which means that it has lost $0.0978 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.7836) %, meaning that it generated substantial loss on money invested by shareholders. Beneficient Warrant's management efficiency ratios could be used to measure how well Beneficient Warrant manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.14 in 2025. Return On Capital Employed is likely to drop to -0.02 in 2025. At this time, Beneficient Warrant's Other Current Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 30 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 333.2 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Tyler Ehler | I Mab | N/A | |
| Min Yin | I Mab | 54 | |
| Mark Mummert | Albemarle | N/A | |
| Fernando Salles | I Mab | N/A | |
| Colleen Donofrio | Ecovyst | 65 | |
| Melissa Anderson | Albemarle | 60 | |
| Weiming Tang | I Mab | 58 | |
| Pete Sr | Catalyst Pharmaceuticals | N/A | |
| Stanley MD | Catalyst Pharmaceuticals | N/A | |
| Louie MD | I Mab | N/A | |
| Glen Merfeld | Albemarle | N/A | |
| Brian Tessin | Albemarle | N/A | |
| John MD | I Mab | 47 | |
| Nachiappan Chidambaram | Lipocine | 56 | |
| Tianyi Zhang | I Mab | N/A | |
| Ka Lo | Kingboard Chemical Holdings | 49 | |
| Stacy Grant | Albemarle | N/A | |
| Eric Norris | Albemarle | 58 | |
| Skelton Joseph | I Mab | 34 | |
| Maria Brennan | Albemarle | 57 | |
| Claire Xu | I Mab | N/A | |
Management Performance
| Return On Equity | -1.78 | ||||
| Return On Asset | -0.0978 |
Beneficient Warrant Leadership Team
Elected by the shareholders, the Beneficient Warrant's board of directors comprises two types of representatives: Beneficient Warrant inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Beneficient. The board's role is to monitor Beneficient Warrant's management team and ensure that shareholders' interests are well served. Beneficient Warrant's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Beneficient Warrant's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maria Rutledge, Chief Officer | ||
| Brad Heppner, Chairman Founder | ||
| Jeff Welday, Global Distribution | ||
| James Silk, Chief VP | ||
| Ambassador Fisher, Director Director | ||
| Gregory Ezell, Chief Officer | ||
| Scott Wilson, Chief Officer | ||
| Maureen Downey, Managing Underwriting | ||
| Casey Brunner, MD Program | ||
| David Rost, General Counsel | ||
| Derek Fletcher, Chief BFF |
Beneficient Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Beneficient Warrant a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.78 | ||||
| Return On Asset | -0.0978 | ||||
| Operating Margin | (0.29) % | ||||
| Number Of Shares Shorted | 13.59 K | ||||
| Revenue | 5.83 M | ||||
| Gross Profit | (85.91 M) | ||||
| EBITDA | (2.74 B) | ||||
| Net Income | (2.1 B) | ||||
| Total Debt | 2.2 M | ||||
| Book Value Per Share | (65.50) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Beneficient Stock Analysis
When running Beneficient Warrant's price analysis, check to measure Beneficient Warrant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beneficient Warrant is operating at the current time. Most of Beneficient Warrant's value examination focuses on studying past and present price action to predict the probability of Beneficient Warrant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beneficient Warrant's price. Additionally, you may evaluate how the addition of Beneficient Warrant to your portfolios can decrease your overall portfolio volatility.